Asian-News.net is your go-to online destination for comprehensive coverage of major news across Asia. From politics and business to culture and technology, we bring you the latest updates, deep analyses, and critical insights from every corner of the continent. Featuring exclusive interviews, high-quality photos, and engaging videos, we keep you informed on the breaking news and significant events shaping Asia. Stay connected with us to get a 24/7 update on the most important stories and trends. Our daily updates ensure that you never miss a beat on the happenings in Asia's diverse nations. Whether it's a political shift in China, economic development in India, technological advancements in Japan, or cultural events in Southeast Asia, Asian-News.net has it covered. Dive into the world of Asian news with us and stay ahead in understanding this dynamic and vibrant region.

Contacts

  • Owner: SNOWLAND s.r.o.
  • Registration certificate 06691200
  • 16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
  • Czech Republic

Karen Gilchrist in asian news

Karen Gilchrist - H&M plunges 13% on doubts over full-year margin target, June sales outlook - cnbc.com - New York - Sweden - city London - city Stockholm - city Paris - city Berlin

H&M plunges 13% on doubts over full-year margin target, June sales outlook

Shares of H&M plunged more than 14% on Thursday morning after the company reported a smaller-than-expected increase in second-quarter profits and cast doubt over its June sales and full-year profit margin target.

Read More
Karen Gilchrist - Novo Nordisk - Novo Nordisk's Wegovy wins EU backing for reducing heart risks - cnbc.com - Britain - Denmark - Eu

Novo Nordisk's Wegovy wins EU backing for reducing heart risks

Novo Nordisk's blockbuster Wegovy weight loss drug has received backing from the European Union's medical regulator to expand the medicine's use to include reducing the rise of serious heart events in overweight and obese adults.

Read More
Karen Gilchrist - Eli Lilly - Novo Nordisk - Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results - cnbc.com - Switzerland

Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results

Roche said Thursday that its Wegovy rival weight loss drugs will be part of a suite of medicines aimed at combatting the effects of obesity.

Read More
Karen Gilchrist - Charles - Charles Iii III (Iii) - Britain's King Charles cashes in as Crown Estate profits surge to over $1.4 billion - cnbc.com - Britain

Britain's King Charles cashes in as Crown Estate profits surge to over $1.4 billion

LONDON — Britain's King Charles III is set for a bumper £45 million ($58 million) pay raise after profits at the sovereign's public estate more than doubled, according to official records.

Read More
Karen Gilchrist - Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment - cnbc.com - Britain - Denmark

Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment

LONDON — The U.K.'s health regulator on Tuesday approved the use of Novo Nordisk's Wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart problems or strokes.

Read More
Karen Gilchrist - Paris Olympics - Olympic track and field gold medalists are about to receive prize money for the first time ever - cnbc.com - Britain - city Paris

Olympic track and field gold medalists are about to receive prize money for the first time ever

World Athletics President Sebastian Coe defended his decision to pay prize money to track and field gold medalists for the first time at the Paris Olympics this summer, suggesting that the initiative could be extended to future games.

Read More
Karen Gilchrist - Eli Lilly - Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche - cnbc.com - Denmark - Switzerland

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate.

Read More
Karen Gilchrist - Taylor Swift - Reuters - UK inflation holds steady at Bank of England's 2% target, above expectations - cnbc.com - Britain

UK inflation holds steady at Bank of England's 2% target, above expectations

U.K. inflation held steady at the Bank of England's 2% target in June, Official National Statistics data showed Wednesday.

Read More
Karen Gilchrist - Hugo Boss shares plunge 9% as firm cuts 2024 guidance amid slumping China demand - cnbc.com - China - Germany

Hugo Boss shares plunge 9% as firm cuts 2024 guidance amid slumping China demand

Hugo Boss shares plunged as much as 10% Tuesday after the company cut its sales outlook, becoming the latest high-end fashion line to warn of persistent woes in the luxury sector.

Read More
Load More